Benign Breast Disease: A New Frontier for Prevention
良性乳腺疾病:预防的新领域
基本信息
- 批准号:7559637
- 负责人:
- 金额:$ 11.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AwardAwarenessBasic ScienceBehavioral SciencesBenignBiological AssayBiological MarkersBiologyBiopsyBiopsy SpecimenBreastBreast Cancer PreventionBreast DiseasesCaringCategoriesChemopreventionClinicalClinical ManagementClinical ProtocolsClinical ResearchCollaborationsCommunitiesCounselingDecision AidDecision MakingDiagnosisDiagnosticDiscriminationDisease ManagementEducationEducational StatusEpidemiologic StudiesFamilyFellowshipFosteringGeneticGoalsHealthHealth PromotionHealthcareHereditary Malignant NeoplasmHistopathologyHuman Genome ProjectIndividualInterventionLeadLesionMalignant NeoplasmsMalignant neoplasm of ovaryMammary Gland ParenchymaMammographyMastectomyMedical OncologyMentorsModelingMolecularMolecular MedicineMolecular ProfilingNatureNormal tissue morphologyOutcomePathologistPatientsPilot ProjectsPopulationPopulation SciencesPreventionPrevention strategyPreventiveProteinsProteomicsProtocols documentationPublic HealthRandomizedRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesRiskRisk MarkerRotationScientistScreening procedureSenior Scientist AwardSeriesSpecimenStudentsTestingTherapeuticTimeTissuesTrainingTranslational ResearchTranslationsUncertaintyUnderserved PopulationWomanWorkbasebreast lesioncancer preventioncancer riskcareerclinical carecopingdisorder preventionfrontierimprovedinterestlaser capture microdissectionmalignant breast neoplasmnovelpreferenceprognosticprogramsprospectivepsychologicstemtheoriestool
项目摘要
DESCRIPTION (provided by applicant): For the past twenty years, I have been involved with the care of women with breast and ovarian cancer, and their families. During that time my research focus has gradually shifted from management of the disease to its prevention. This direction has been enhanced by the work of the Human Genome Project, which has made tremendous progress in advancing our understanding of the genetic basis of cancer, and by the increased awareness on the part of both the public and the health care community of the tremendous potential for disease prevention and control. Building on this framework, I have developed a nationally recognized research-based program, defined by familial cancer risk, in which to explore novel education and counseling interventions and prevention strategies. I have formed longstanding collaborations with colleagues in the basic sciences, population sciences and behavioral sciences to foster translational research. I have contributed to the training of scientists at many levels who are new to the field of cancer prevention and control. I represent one of a handful of investigators in the field of cancer prevention and control who combines theory-driven research initiatives with actual translation to the clinical setting. At this point in my career, the K05 award will allow me to extend these efforts to a growing and underserved population of women who are at increased risk for breast cancer because of a diagnosis of benign breast disease. In the new era of molecular medicine, this population provides an ideal opportunity to study early molecular signatures of cancer risk, to identify genetic modifiers of risk, and to tailor preventive options to the biology of the lesion. The award will also facilitate my efforts to formalize a novel clinical genetics training rotation within the medical oncology fellowship, and will afford more opportunities to mentor students at all levels of training.
描述(由申请人提供):在过去的二十年中,我参与了乳腺癌和卵巢癌及其家人的照顾。在此期间,我的研究重点逐渐从疾病的管理转变为预防。人类基因组项目的工作增强了这一方向,这在促进了我们对癌症遗传基础的理解以及公众和卫生保健社区对疾病预防和控制的巨大潜力的认识方面取得了巨大进展。在此框架的基础上,我开发了一个由家庭癌症风险定义的全国认可的基于研究的计划,以探索新颖的教育和咨询干预措施和预防策略。我已经与基础科学,人口科学和行为科学的同事建立了长期的合作,以促进转化研究。我为在癌症预防和控制领域的许多层面上的科学家培训做出了贡献。我代表了癌症预防和控制领域的少数研究人员之一,他们将理论驱动的研究计划与实际转化为临床环境相结合。在我职业生涯的这一点上,K05奖将使我能够将这些努力扩展到日益增长的妇女人群,这些妇女因诊断出良性乳腺癌而患乳腺癌的风险增加。在分子医学的新时代,该人群为研究癌症风险的早期分子特征,确定风险的遗传改性剂,并为病变生物学量身定制预防选择。该奖项还将促进我在医学肿瘤学奖学金中进行新型临床遗传学培训轮换的正式努力,并将为在各个培训级别的各个培训中提供更多机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY Beryl DALY其他文献
MARY Beryl DALY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY Beryl DALY', 18)}}的其他基金
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C
改善 BRCA1/2 C 人群卵巢癌风险的评估和沟通
- 批准号:
8380816 - 财政年份:2012
- 资助金额:
$ 11.61万 - 项目类别:
Personalized Medicine: Understanding and Utilization by Health Care Providers
个性化医疗:医疗保健提供者的理解和利用
- 批准号:
7942950 - 财政年份:2009
- 资助金额:
$ 11.61万 - 项目类别:
Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C
改善 BRCA1/2 C 人群卵巢癌风险的评估和沟通
- 批准号:
7727488 - 财政年份:2009
- 资助金额:
$ 11.61万 - 项目类别:
Personalized Medicine: Understanding and Utilization by Health Care Providers
个性化医疗:医疗保健提供者的理解和利用
- 批准号:
7742703 - 财政年份:2009
- 资助金额:
$ 11.61万 - 项目类别:
Personalized Medicine: Understanding and Utilization by Health Care Providers
个性化医疗:医疗保健提供者的理解和利用
- 批准号:
8141867 - 财政年份:2009
- 资助金额:
$ 11.61万 - 项目类别:
Facilitating Web-based Patient Decision Support for Hereditary Breast Cancer Risk
促进基于网络的遗传性乳腺癌风险患者决策支持
- 批准号:
7575262 - 财政年份:2008
- 资助金额:
$ 11.61万 - 项目类别:
Benign Breast Disease: A New Frontier for Prevention
良性乳腺疾病:预防的新领域
- 批准号:
7369774 - 财政年份:2005
- 资助金额:
$ 11.61万 - 项目类别:
Benign Breast Disease: A New Frontier for Prevention
良性乳腺疾病:预防的新领域
- 批准号:
7022195 - 财政年份:2005
- 资助金额:
$ 11.61万 - 项目类别:
Benign Breast Disease: A New Frontier for Prevention
良性乳腺疾病:预防的新领域
- 批准号:
6856701 - 财政年份:2005
- 资助金额:
$ 11.61万 - 项目类别:
Benign Breast Disease: A New Frontier for Prevention
良性乳腺疾病:预防的新领域
- 批准号:
7224862 - 财政年份:2005
- 资助金额:
$ 11.61万 - 项目类别:
相似国自然基金
意识障碍康复的神经血管跨模态信息耦合预测-评估模型与自适应调控策略
- 批准号:62376190
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于神经功能影像技术研究腹侧基底核在丙泊酚诱导意识状态改变中的作用
- 批准号:82301443
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于丘脑-前额叶皮层环路的经耳迷走神经刺激对意识障碍的作用及机制研究
- 批准号:82302852
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DAVTA-5-HTDRN神经环路调控丙泊酚全麻小鼠意识改变的作用机制研究
- 批准号:82360242
- 批准年份:2023
- 资助金额:31.5 万元
- 项目类别:地区科学基金项目
基于操控员情境意识状态可解释Agent的智能交互触发机制研究
- 批准号:62376220
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
40th National Neurotrauma Society (NNS) Annual Symposium 2023 - Celebrating the Landmarks of Neurotrauma
2023 年第 40 届国家神经创伤协会 (NNS) 年度研讨会 - 庆祝神经创伤的里程碑
- 批准号:
10753817 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
Inhaled Aerosol Dosimetry: Advances, Applications, and Impacts on Risk Assessments and Therapeutics
吸入气溶胶剂量测定:进展、应用以及对风险评估和治疗的影响
- 批准号:
10752525 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:
10752090 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别:
Raise Awareness In Students Early (RAISE) Host and Microbe Program
早期提高学生意识 (RAISE) 宿主和微生物计划
- 批准号:
10628899 - 财政年份:2023
- 资助金额:
$ 11.61万 - 项目类别: